The central nervous system (CNS) biomarkers market covers measurable biological indicators used to detect, stratify, monitor, and predict neurological and neuropsychiatric conditions, supporting both clinical decision-making and drug development. Biomarkers span molecular measures in cerebrospinal fluid and blood, genetic and epigenetic markers, neuroimaging readouts, electrophysiolog... https://www.oganalysis.com/industry-reports/central-nervous-system-biomarkers-market